(GalNAc) 3-CPT

CAT: 0931-T212503-01Size: 10 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0931-T212503-01Size:10 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Target

Phosphatase, Apoptosis

Related Pathways

Metabolism, Apoptosis

Bioactivity

(GalNAc) 3-CPT is a glycan-conjugated prodrug that targets the asialoglycoprotein receptor (ASGR) overexpressed on liver cells. It demonstrates significant antitumor activity by activating the cGAS-STING pathway and promoting CD8+ T cell infiltration into tumor sites, leading to apoptosis of tumor cells. In HepG2 cells, it shows an IC50 value of 3.07 μM.

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Related Products

Catalog	Name
T77946-01	Tri-GalNAc (OAc) 3
T73422-01	CPT-Se4
T41018-01	CPT-157633
T73421-01	CPT-Se3
T208816-01	IRGD-CPT
T77947-01	Tri-GalNAc (OAc) 3 TFA
T77935	Tri-GalNAc (OAc) 3-Perfluorophenyl
TYD-01160-01	Gal-β1,3-GalNAc-β-OMe
TYD-01126-01	GlcNAcβ (1-3) GalNAc-α-Thr
TYD-01116-01	GalNAcβ (1-3) GlcNAc-β-pNP

Alternative Products

Catalog	Name
HY-175472	(GalNAc) 3-CPT
GTR19231310-01	Tri-GalNAc (OAc) 3
MBS5819617	Tri-GalNAc(OAc)3
HY-173261	Tri-GalNAc (OAc) 3-Cbz
HY-145368B-01	Tri-GalNAc (OAc) 3-Perfluorophenyl
GIC55326-01	Galnacβ (1-3) GlcNAc-β-PNP
HY-W145586	GlcNAcβ (1-3) GalNAc-α-Thr
MBS5819618	Tri-GalNAc(OAc)3 TFA
sc-224005	GlcNAc-β-1,3-GalNAc-α-PNP
GTR19247445-01	Galβ (1-3) GalNAc-β-pNP

(GalNAc) 3-CPT

Related Products

Alternative Products

Popular Products